✦ LIBER ✦

Hypofractionated Intensity Modulated Radiation Therapy in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer

✍ Scribed by Turgeon, Guy-Anne; Souhami, Luis; Cury, Fabio L.; Faria, Sergio L.; Duclos, Marie; Sturgeon, Jeremy; Kassouf, Wassim

Book ID: 122257376
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 244 KB
Volume: 88
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypofractionation IMRT in Combined Modal

Hypofractionation IMRT in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer

✍ Turgeon, G.A.; Souhami, L.; Cury, F.L.; Faria, S.L.; Duclos, M.; Sturgeon, J.; K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Opportunities with combined modality the

Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer

✍ Colvett, Kyle T.; Althausen, Alex F.; Bassil, Barbara; Heney, Niall M.; McGovern 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 830 KB

Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surger

Combined cisplatin and radiation therapy

Combined cisplatin and radiation therapy in patients with invasive bladder cancer

✍ Y. Mori; H. Ihara; H. Shima; K. Shimada; M. Arima; F. Ikoma 📂 Article 📅 1990 🏛 Springer Netherlands 🌐 English ⚖ 1004 KB

790 SELECTIVE ORGAN PRESERVATION IN MUSC

790 SELECTIVE ORGAN PRESERVATION IN MUSCLE-INVASIVE BLADDER CANCER: THE CASE FOR A COMBINED MODALITY TREATMENT

✍ S. Perdona; R. Autorino; M. De Sio; L. Gallo; A. Gallo; G. Di Lorenzo; R. Damian 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Quality of life assessment in women afte

Quality of life assessment in women after combined modality treatment with bladder conservation for invasive bladder cancer

✍ L.A. Kachnic; W.U. Shipley; P.P. Griffin; A.L. Zietman; J.J. Coen; C.M. Mannix; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Phase III Trial of Neoadjuvant Chemother

Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03

✍ Shipley, W.U.; Winter, K.A.; Kaufman, D.S.; Lee, W.R.; Heney, N.M.; Tester, W.R. 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 227 KB